Pomalidomide-PEG2-butyl iodide

Pomalidomide-PEG2-butyl iodide Struktur
1835705-72-0
CAS-Nr.
1835705-72-0
Englisch Name:
Pomalidomide-PEG2-butyl iodide
Synonyma:
Pomalidomide-2-2-6-I;Pomalidomide-PEG2-butyl iodide;Acetamide, N-[2-(2,6-dioxo-3-piperidinyl)-2,3-dihydro-1,3-dioxo-1H-isoindol-4-yl]-2-[2-[(6-iodohexyl)oxy]ethoxy]-;Crosslinker–E3 Ligase ligand conjugate, Pomalidomide-2-2-6-I, N-(2-(2,6-Dioxopiperidin-3-yl)-1,3-dioxoisoindolin-4-yl)-2-(2-((6-iodohexyl)oxy)ethoxy)acetamide, Protein degrader building block for PROTAC? research, Template for synthesis of targeted protein degrader
CBNumber:
CB74919985
Summenformel:
C23H28IN3O7
Molgewicht:
585.39
MOL-Datei:
1835705-72-0.mol

Pomalidomide-PEG2-butyl iodide Eigenschaften

Siedepunkt:
757.7±60.0 °C(Predicted)
Dichte
1.588±0.06 g/cm3(Predicted)
storage temp. 
2-8°C
pka
10.68±0.40(Predicted)

Sicherheit

Pomalidomide-PEG2-butyl iodide Chemische Eigenschaften,Einsatz,Produktion Methoden

Verwenden

Protein degrader builiding block Pomalidomide-PEG2-butyl Iodide enables the synthesis of molecules for targeted protein degradation and PROTAC (proteolysis-targeting chimeras) technology. This conjugate contains a Cereblon (CRBN)-recruiting ligand, a linker with both hydrophobic and hydrophilic moieties, and a pendant iodoalkane for reactivity with a nucleophilic group on a target ligand. Because even slight alterations in ligands and crosslinkers can affect ternary complex formation between the target, E3 ligase, and PROTAC, many analogs are prepared to screen for optimal target degradation. When used with other protein degrader building blocks with a pendant iodo group, parallel synthesis can be used to more quickly generate PROTAC libraries that feature variation in crosslinker length, composition, and E3 ligase ligand.

Pomalidomide-PEG2-butyl iodide Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte


Pomalidomide-PEG2-butyl iodide Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Global( 12)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
LEAP CHEM CO., LTD.
+86-852-30606658
market18@leapchem.com China 24738 58
Xian confluore Biological Technology Co., Ltd.
+86-15680926068 +86-15680926068
1924344760@confluore.cn China 2893 58
Aladdin Scientific
+1-833-552-7181
sales@aladdinsci.com United States 57511 58
Sigma-Aldrich 021-61415566 800-8193336
orderCN@merckgroup.com China 51471 80
Shanghai Chaolan Chemical Technology Center QQ:65489617 15618227136
info@SuperLan-chem.com China 9445 58
Xi'an Confluore Biological Technology Co., Ltd. +86-156-80926068 +86-15680926068
1924344760@qq.com China 4955 58
Jilin Province Woda Biotechnology Co., Ltd. 13504435624
1927928688@qq.com China 1290 58
Shaanxi borno biotechnology co., LTD +86-13759708231
asherw9@hotmail.com China 2351 58
Zhengzhou convergence chemical co., LTD 0371-0371-55153829 18003835034
2853979819@qq.com China 8610 58
Changzhou Bojia Biomedical Technology Co., Ltd. 2122619822
czbjpharma@126.com China 18488 58

  • Pomalidomide-2-2-6-I
  • Acetamide, N-[2-(2,6-dioxo-3-piperidinyl)-2,3-dihydro-1,3-dioxo-1H-isoindol-4-yl]-2-[2-[(6-iodohexyl)oxy]ethoxy]-
  • Pomalidomide-PEG2-butyl iodide
  • Crosslinker–E3 Ligase ligand conjugate, Pomalidomide-2-2-6-I, N-(2-(2,6-Dioxopiperidin-3-yl)-1,3-dioxoisoindolin-4-yl)-2-(2-((6-iodohexyl)oxy)ethoxy)acetamide, Protein degrader building block for PROTAC? research, Template for synthesis of targeted protein degrader
  • 1835705-72-0
  • C23H28IN3O7
Copyright 2019 © ChemicalBook. All rights reserved